Mirage Hydrophilic Guidewire X-Pedion Hydrophilic Guidewire
Micro Therapeutics Inc., D/B/A Ev3 Neurovascular
Product: X-pedion — all models and sizes
FDA Clearance Information
The Mirage and X-Pedion guidewires were cleared through the FDA 510(k) pathway on July 21, 2020. Manufactured by Micro Therapeutics Inc., D/B/A Ev3 Neurovascular, these devices are classified as Class 2 under product code DQX.
What It Is
FDA-Cleared Indications
- Intended for use to facilitate the placement and positioning of catheters during intravascular procedures.
- Used in procedures involving the delivery of embolization agents.
- For use by trained clinicians when vascular access and catheter navigation are required.
Clinical Applications
- Navigating a catheter through the vasculature during embolization procedures.
- Facilitating catheter placement for endovascular treatment of vascular abnormalities when embolic agents are delivered.
- Supporting selective catheterization of vessels that are difficult to access because of tortuosity or complex anatomy.
Practical Considerations
- The wire must be selected in a diameter and length compatible with the intended catheter, access route and vascular anatomy.
- Hydrophilic guidewires should be prepared and handled according to the manufacturer’s instructions to maintain lubrication and reduce coating damage.
- Use continuous fluoroscopic guidance and avoid excessive force, deep advancement against resistance or sharp bending, which can contribute to vessel injury or wire damage.
- Compatibility with a specific catheter or embolic delivery system should be confirmed before use; the guidewire is not itself an embolic agent.
- MRI safety depends on the exact model and labeling. The device should not be assumed to be MR safe or MR conditional unless the current manufacturer’s instructions specifically provide that information.
Linked Studies (20)
Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.
Journal of neuroendovascular therapy
RCT|prospective|retrospective|case Series|other View Source →Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.
Clinical chemistry and laboratory medicine
RCT|prospective|retrospective|case Series|other View Source →Clinical progress note: Haemophilus influenzae type b.
Journal of hospital medicine
RCT|prospective|retrospective|case Series|other View Source →Pilot study of social media promotion of home-based self-testing for syphilis.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.
Journal of clinical microbiology
View Source →Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.
Sexually transmitted diseases
RCT|prospective|retrospective|case Series|other View Source →Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.
Florida public health review
View Source →Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.
Frontiers in cellular and infection microbiology
RCT|prospective|retrospective|case Series|other View Source →Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.
Transboundary and emerging diseases
View Source →Tp40: a new potential prognostic and diagnostic marker for syphilis.
Microbiology spectrum
View Source →Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.
The Journal of clinical investigation
RCT|prospective|retrospective|case Series|other View Source →Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.
Hellenic journal of nuclear medicine
RCT|prospective|retrospective|case Series|other View Source →Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.
Biochemistry and cell biology = Biochimie et biologie cellulaire
View Source →Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.
Journal of Yeungnam medical science
RCT View Source →pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.
Magnetic resonance in medicine
RCT|prospective|retrospective|case Series|other View Source →Comparative connectomics of Drosophila descending and ascending neurons.
Nature
RCT|prospective|retrospective|case Series|other View Source →Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences
View Source →History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.
Zeitschrift fur Rheumatologie
View Source →A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.
BioMed research international
RCT|prospective|retrospective|case Series|other View Source →Frequently Asked Questions
What is Mirage & X-Pedion guidewires used for?
They are used for navigating vascular systems during embolization procedures, particularly in treating aneurysms and arteriovenous malformations.
What specialties typically use this device?
Interventional radiologists and neurosurgeons commonly use these guidewires in endovascular procedures.
What are the FDA-cleared indications?
These guidewires are indicated for use in procedures involving the delivery of embolization agents to treat vascular abnormalities.